article · International Journal of Gynecological Cancer

Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

Whitney A. Spannuth Graybill
Bradley J. Monk
Alfonso Yubero
Philippe Follana
Elena Ioana Braicu
Colleen McCormick
Richard G Moore
Peter Vuylsteke
Whitney York
John Hartman
Beatriz Pardo Búrdalo
David M O’Malley
Ignace Vergote
Annika Auranen
Larry J Copeland
Roberto Sabbatini
Thomas J Herzog
Nicoline Raaschou-Jensen
Bhavana Pothuri
Antonio González-Martı́n

20248 citationsOpen accessUniversity of Botswana

In plain language

No abstract is available for this record, so no summary has been generated.

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1136/ijgc-2024-005356

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.

Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

In plain language

Research topics

Read the original research

Discuss this research